Abstract:The combination of chemotherapy and photothermal therapy (PTT) into a single formulation has attracted increasing attention as a strategy for enhancing cancer treatment. Here, hollow mesoporous silica nanoparticles (HMSNs) were used as a base carrier material, loaded with the anti-cancer drug doxorubicin (DOX), and surface functionalized with chitosan (CS) and copper sulfide (CuS) nanodots to give In this formulation, the CuS dots act as gatekeepers to seal the surface pores of the HMSNs, preventing a burst release of DOX into the systemic circulation. S-S bonds connect the CuS dots to the HMSNs; these are selectively cleaved under the reducing microenvironment of the tumor, permitting targeted drug release. This, coupled with the PTT properties of CuS, results in a potent chemo/PTT platform. The nanoparticles have a uniform size (150 ± 13 nm), potent photothermal properties (η= 36.4 %), and tumor-targeted and near infrared (NIR) laser irradiation-triggered DOX release. In vitro and in vivo experimental results confirmed that the material has good biocompatibility, but is effectively taken up by cancer cells. Moreover, the CuS nanodots permit, simultaneous thermal/photoacoustic dual-modality imaging. Treatment with and NIR irradiation caused extensive apoptosis in cancer cells both in vitro and in vivo, and could dramatically extend the lifetimes of animals in a murine breast cancer model. The system developed in this work therefore merits further investigation as a potential nanotheranostic platform for cancer treatment.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Statement of Significance</h3>: Conventional cancer chemotherapy is accompanied by unavoidable off-target toxicity. Combination therapies, which can ameliorate these issues, are attracting significant attention. Here, the anticancer drug doxorubicin (DOX) was encapsulated in the central cavity of chitosan (CS)-modified hollow mesoporous silica nanoparticles (HMSNs). The prepared system can target drug release to the tumor microenvironment. When exposed to near infrared laser (NIR) irradiation, CuS nanodots located at the surface pores of the HMSNs generate energy, accelerating drug release. In addition, a systematic in vitro and in vivo evaluation confirmed the platform to give highly effective synergistic chemotherapeutic-photothermal therapy and have effective thermal/photoacoustic dual-imaging properties. This work may open up a new avenue for NIR-enhanced synergistic therapy with simultaneous thermal/photoacoustic dual imaging.

Biodegradable Mesoporous Organosilica Nanosheets for Chemotherapy/Mild Thermotherapy of Cancer: Fast Internalization, High Cellular Uptake, and High Drug Loading.

Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery

A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy

pH/glutathione dual-responsive copper sulfide-coated organic mesoporous silica for synergistic chemo-photothermal therapy

Biodegradable Theranostic Nanoplatforms of Albumin-Biomineralized Nanocomposites Modified Hollow Mesoporous Organosilica for Photoacoustic Imaging Guided Tumor Synergistic Therapy

Biodegradable Hollow Mesoporous Organosilica-Based Nanosystems with Dual Stimuli-Responsive Drug Delivery for Efficient Tumor Inhibition by Synergistic Chemo- and Photothermal Therapy

Molecularly Organic/inorganic Hybrid Hollow Mesoporous Organosilica Nanocapsules with Tumor-Specific Biodegradability and Enhanced Chemotherapeutic Functionality

Dual Gatekeepers-Modified Mesoporous Organic Silica Nanoparticles for Synergistic Photothermal-Chemotherapy of Breast Cancer.

Cisplatin and Doxorubicin High-Loaded Nanodrug Based on Biocompatible Thioether- and Ethane-Bridged Hollow Mesoporous Organosilica Nanoparticles.

Monolayer Nanosheets with an Extremely High Drug Loading toward Controlled Delivery and Cancer Theranostics.

Mesoporous organosilica nanoparticles: Degradation strategies and application in tumor therapy

Cellular defense system-destroying nanoparticles as a platform for enhanced chemotherapy against drug-resistant cancer

Controllable Synthesis of Versatile Mesoporous Organosilica Nanoparticles As Precision Cancer Theranostics

Walnut kernel-like mesoporous silica nanoparticles as effective drug carrier for cancer therapy in vitro

A Multifunctional Biodegradable Nanocomposite For Cancer Theranostics

Functionalized Periodic Mesoporous Organosilica Nanoparticles for Combinational Chemo-Photothermal Antitumor Therapy

High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy.

Aptamer-functionalized Molybdenum Disulfide Nanosheets for Tumor Cell Targeting and Lysosomal Acidic Environment/nir Laser Responsive Drug Delivery to Realize Synergetic Chemo-Photothermal Therapeutic Effects.

Bi2S3-embedded Mesoporous Silica Nanoparticles for Efficient Drug Delivery and Interstitial Radiotherapy Sensitization.

Multifunctional MoS2 Nanosheets with Au NPs Grown in Situ for Synergistic Chemo-Photothermal Therapy.

Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer